×
S&P 500   3,777.92 (-1.24%)
DOW   30,586.53 (-1.64%)
QQQ   281.98 (-0.05%)
AAPL   139.47 (+0.39%)
MSFT   257.49 (-0.81%)
META   164.52 (+2.81%)
GOOGL   2,205.11 (+1.40%)
AMZN   112.07 (+2.29%)
TSLA   681.37 (-0.06%)
NVDA   146.70 (+1.01%)
NIO   21.73 (+1.73%)
BABA   115.86 (-0.12%)
AMD   74.25 (+0.79%)
MU   55.39 (+3.24%)
CGC   2.63 (-6.41%)
T   20.88 (-2.02%)
GE   60.93 (-4.11%)
F   10.97 (-3.09%)
DIS   95.01 (-1.18%)
AMC   12.72 (-5.99%)
PFE   50.50 (-3.46%)
PYPL   73.20 (+2.52%)
NFLX   182.32 (+1.32%)
S&P 500   3,777.92 (-1.24%)
DOW   30,586.53 (-1.64%)
QQQ   281.98 (-0.05%)
AAPL   139.47 (+0.39%)
MSFT   257.49 (-0.81%)
META   164.52 (+2.81%)
GOOGL   2,205.11 (+1.40%)
AMZN   112.07 (+2.29%)
TSLA   681.37 (-0.06%)
NVDA   146.70 (+1.01%)
NIO   21.73 (+1.73%)
BABA   115.86 (-0.12%)
AMD   74.25 (+0.79%)
MU   55.39 (+3.24%)
CGC   2.63 (-6.41%)
T   20.88 (-2.02%)
GE   60.93 (-4.11%)
F   10.97 (-3.09%)
DIS   95.01 (-1.18%)
AMC   12.72 (-5.99%)
PFE   50.50 (-3.46%)
PYPL   73.20 (+2.52%)
NFLX   182.32 (+1.32%)
S&P 500   3,777.92 (-1.24%)
DOW   30,586.53 (-1.64%)
QQQ   281.98 (-0.05%)
AAPL   139.47 (+0.39%)
MSFT   257.49 (-0.81%)
META   164.52 (+2.81%)
GOOGL   2,205.11 (+1.40%)
AMZN   112.07 (+2.29%)
TSLA   681.37 (-0.06%)
NVDA   146.70 (+1.01%)
NIO   21.73 (+1.73%)
BABA   115.86 (-0.12%)
AMD   74.25 (+0.79%)
MU   55.39 (+3.24%)
CGC   2.63 (-6.41%)
T   20.88 (-2.02%)
GE   60.93 (-4.11%)
F   10.97 (-3.09%)
DIS   95.01 (-1.18%)
AMC   12.72 (-5.99%)
PFE   50.50 (-3.46%)
PYPL   73.20 (+2.52%)
NFLX   182.32 (+1.32%)
S&P 500   3,777.92 (-1.24%)
DOW   30,586.53 (-1.64%)
QQQ   281.98 (-0.05%)
AAPL   139.47 (+0.39%)
MSFT   257.49 (-0.81%)
META   164.52 (+2.81%)
GOOGL   2,205.11 (+1.40%)
AMZN   112.07 (+2.29%)
TSLA   681.37 (-0.06%)
NVDA   146.70 (+1.01%)
NIO   21.73 (+1.73%)
BABA   115.86 (-0.12%)
AMD   74.25 (+0.79%)
MU   55.39 (+3.24%)
CGC   2.63 (-6.41%)
T   20.88 (-2.02%)
GE   60.93 (-4.11%)
F   10.97 (-3.09%)
DIS   95.01 (-1.18%)
AMC   12.72 (-5.99%)
PFE   50.50 (-3.46%)
PYPL   73.20 (+2.52%)
NFLX   182.32 (+1.32%)
NYSE:AMWL

American Well Stock Forecast, Price & News

$4.46
+0.04 (+0.90%)
(As of 07/5/2022 12:21 PM ET)
Add
Compare
Today's Range
$4.26
$4.46
50-Day Range
$2.61
$5.21
52-Week Range
$2.52
$12.56
Volume
26,424 shs
Average Volume
2.64 million shs
Market Capitalization
$1.19 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00

American Well MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.56 Rating Score
Upside/​Downside
107.9% Upside
$9.00 Price Target
Short Interest
Bearish
5.49% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.60mentions of American Well in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$1.52 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.98) to ($0.68) Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.99 out of 5 stars

Medical Sector

509th out of 1,428 stocks

Business Services, Not Elsewhere Classified Industry

47th out of 146 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive AMWL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for American Well and its competitors with MarketBeat's FREE daily newsletter.

American Well logo

About American Well (NYSE:AMWL) Stock

American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

AMWL Stock News Headlines

Brokerages Set American Well Co. (NYSE:AMWL) PT at $9.00
American Well (NYSE:AMWL) Shares Gap Up to $4.62
American Well (NYSE:AMWL) Stock Price Down 3.4%
This Underrated Growth Stock Soared 20% in May
Amwell (AMWL) Q1 2022 Earnings Call Transcript
Amwell Announces Results for First Quarter 2022
American Well Q1 2022 Earnings Preview
See More Headlines

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
1,035
Year Founded
N/A

Company Calendar

Last Earnings
5/09/2022
Today
7/05/2022
Next Earnings (Estimated)
8/10/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$9.00
High Stock Price Forecast
$18.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+101.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.55555555555556
Research Coverage
9 Analysts

Profitability

Net Income
$-176,330,000.00
Pretax Margin
-81.23%

Debt

Sales & Book Value

Annual Sales
$252.79 million
Book Value
$4.81 per share

Miscellaneous

Free Float
227,211,000
Market Cap
$1.19 billion
Optionable
Not Optionable
Beta
0.22














American Well Frequently Asked Questions

Should I buy or sell American Well stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for American Well in the last twelve months. There are currently 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" American Well stock.
View analyst ratings for American Well
or view top-rated stocks.

What is American Well's stock price forecast for 2022?

9 brokerages have issued twelve-month price objectives for American Well's shares. Their AMWL stock forecasts range from $4.00 to $18.00. On average, they predict American Well's share price to reach $9.00 in the next twelve months. This suggests a possible upside of 101.8% from the stock's current price.
View analysts' price targets for American Well
or view top-rated stocks among Wall Street analysts.

How has American Well's stock performed in 2022?

American Well's stock was trading at $6.04 at the start of the year. Since then, AMWL stock has decreased by 26.2% and is now trading at $4.46.
View the best growth stocks for 2022 here
.

Are investors shorting American Well?

American Well saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 9,990,000 shares, an increase of 28.2% from the May 31st total of 7,790,000 shares. Based on an average daily volume of 2,810,000 shares, the days-to-cover ratio is presently 3.6 days. Approximately 5.5% of the shares of the stock are short sold.
View American Well's Short Interest
.

When is American Well's next earnings date?

American Well is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022.
View our earnings forecast for American Well
.

How were American Well's earnings last quarter?

American Well Co. (NYSE:AMWL) issued its quarterly earnings results on Monday, May, 9th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.22) by $0.04. The business earned $64.20 million during the quarter, compared to the consensus estimate of $64.94 million. American Well had a negative net margin of 79.91% and a negative trailing twelve-month return on equity of 16.72%. The company's revenue for the quarter was up 11.5% on a year-over-year basis. During the same period last year, the business posted ($0.16) EPS.
View American Well's earnings history
.

What guidance has American Well issued on next quarter's earnings?

American Well issued an update on its FY 2022 earnings guidance on Monday, June, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $275.00 million-$285.00 million, compared to the consensus revenue estimate of $279.47 million.

Who are American Well's key executives?

American Well's management team includes the following people:

What other stocks do shareholders of American Well own?

Based on aggregate information from My MarketBeat watchlists, some companies that other American Well investors own include PayPal (PYPL), NVIDIA (NVDA), Shopify (SHOP), Tesla (TSLA), Twilio (TWLO), Salesforce (CRM), Livongo Health (LVGO), Skyworks Solutions (SWKS), Slack Technologies (WORK) and Adobe (ADBE).

When did American Well IPO?

(AMWL) raised $525 million in an initial public offering on Thursday, September 17th 2020. The company issued 35,000,000 shares at $14.00-$16.00 per share. Morgan Stanley, Goldman Sachs, PIper Sandler, UBS Investment Bank, Credit Suisse, Cowen and Berenberg acted as the underwriters for the IPO.

What is American Well's stock symbol?

American Well trades on the New York Stock Exchange (NYSE) under the ticker symbol "AMWL."

How do I buy shares of American Well?

Shares of AMWL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is American Well's stock price today?

One share of AMWL stock can currently be purchased for approximately $4.46.

How much money does American Well make?

American Well (NYSE:AMWL) has a market capitalization of $1.19 billion and generates $252.79 million in revenue each year. The company earns $-176,330,000.00 in net income (profit) each year or ($0.79) on an earnings per share basis.

How many employees does American Well have?

American Well employs 1,035 workers across the globe.

How can I contact American Well?

American Well's mailing address is 75 STATE STREET 26TH FLOOR, Boston MA, 02109. The official website for American Well is amwell.com. The company can be reached via phone at 617-205-3500 or via email at investors@amwell.com.

This page (NYSE:AMWL) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.